From left to right: Markus von Raumer, Alexander Denninger, Karl Wagner, Olivia Merkel, Tobias Kapp, José de Chastonay, Chantal Pichon, Christoph Rosenbohm, Mereike Helmdach, Julien Villaumié, Chiara De Rosa, Serra Gürcan, Roderich Süssmuth, Eleanora Fratus, Uwe Albrecht, Alex Talbot, Clemens Horn, Michael Vogel, Adriano Indolese, Jean-Christophe Monbaliu, Stephane Laval, Olivier Legrand, Emanuele Russo, Jason Coleman, Lin Chen
On 3-4 September, 2025, CordenPharma held our third annual Technology & Science Advisory Board (TSAB) meeting in Bergamo, Italy, bringing together world-class chemical and pharmaceutical experts from academia and industry.
Over two days of intensive exchange, TSAB members and CordenPharma subject matter experts explored emerging trends, cutting-edge technologies, regulatory developments, and new project ideas across all six CordenPharma technology platforms.
The TSAB was established to provide specialized scientific and technological expertise that drives strategic decisions, fuels innovation, and advances our long-term growth. Guided by our passion for scientific excellence and our commitment to remain at the forefront of the pharmaceutical and biotechnology industries, TSAB members help harness valuable knowledge and insights to support your complex modalities and evolving needs in developing life-saving medicines and improving patient outcomes.
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.